Wei‐Jan Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 5
- RNA Research and Splicing 3
-
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Wei‐Wen Kuo (2 shared papers)Mien‐Chie Hung (16 shared papers)Hoang Dang Khoa Ta (10 shared papers)Gangga Anuraga (10 shared papers)Chih‐Yang Wang (9 shared papers)Cheng‐Wen Lin (3 shared papers)Tung‐Yuan Lai (1 shared paper)Pei‐Ying Pai (1 shared paper)
- Journals
- Journal of Personalized Medicine (3 papers)International Journal of Medical Sciences (3 papers)Aging (2 papers)International Journal of Molecular Sciences (2 papers)International Journal of Biological Sciences (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Wei‐Jan Wang
39 papers receiving 848 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 116
- Complementary and alternative medicine 49
- Molecular Biology 363
- Biochemistry 27
- Biochemistry 28
Countries citing papers authored by Wei‐Jan Wang
This map shows the geographic impact of Wei‐Jan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Jan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Jan Wang more than expected).
Fields of papers citing papers by Wei‐Jan Wang
This network shows the impact of papers produced by Wei‐Jan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Jan Wang. The network helps show where Wei‐Jan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Jan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 102 | |
| 2 | 2012 | 92 | |
| 3 | Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease. | 2020 | 69 |
| 4 | 2021 | 63 | |
| 5 | 2016 | 52 | |
| 6 | 2013 | 37 | |
| 7 | 2015 | 37 | |
| 8 | 2021 | 33 | |
| 9 | 2016 | 32 | |
| 10 | 2015 | 26 | |
| 11 | 2021 | 25 | |
| 12 | 2021 | 25 | |
| 13 | Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma. | 2020 | 21 |
| 14 | 2021 | 19 | |
| 15 | 2023 | 18 | |
| 16 | Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2. | 2022 | 16 |
| 17 | 2021 | 15 | |
| 18 | 2022 | 14 | |
| 19 | 2022 | 14 | |
| 20 | 2022 | 13 |
About Wei‐Jan Wang
Wei‐Jan Wang is a scholar working on Molecular Biology, Cancer Research, Infectious Diseases, Pulmonary and Respiratory Medicine and Oncology, having authored 42 papers that have together received 861 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers), COVID-19 Clinical Research Studies (4 papers), Ferroptosis and cancer prognosis (4 papers), Computational Drug Discovery Methods (4 papers), RNA Research and Splicing (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (116 citations), Complementary and alternative medicine (49 citations), Molecular Biology (363 citations), Biochemistry (27 citations) and Biochemistry (28 citations). Wei‐Jan Wang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Wei‐Wen Kuo, Mien‐Chie Hung, Hoang Dang Khoa Ta, Gangga Anuraga, Chih‐Yang Wang, Cheng‐Wen Lin, Tung‐Yuan Lai, Pei‐Ying Pai, Hsi‐Hsien Hsu and Shao‐Chun Wang. Their work appears in journals such as Journal of Personalized Medicine, International Journal of Medical Sciences, Aging, International Journal of Molecular Sciences and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.